Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
Cash-strapped Alopexx reignites plans to go public via $30M IPO
Alopexx has resuscitated plans for a public listing as the biotech seeks urgently needed funds to advance its pipeline.
James Waldron
Jun 27, 2026 8:16am
UPDATED: Kardigan buttons up $400M upsized IPO for phase 3 push
Jun 18, 2026 7:28am
Biotech IPOs here to stay after another record-breaking listing
Jun 12, 2026 11:00am
Kardigan plans to bring in cozy $320M haul from upcoming IPO
Jun 11, 2026 8:14am
Parabilis’ upsized $670M IPO breaks new record for biotechs
Jun 10, 2026 4:36am
Despite headwinds, biotech industry charges forward behind M&A
Jun 9, 2026 12:41pm
